MADISON, Wis., Nov. 16, 2012 /PRNewswire/ -- Forte Research Systems, a leading developer of specialized clinical trial management system (CTMS) software, announced today that it has ranked number 303 on Deloitte's Technology Fast 500™, a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. The company achieved this ranking with a four-year growth rate of 251 percent.
Srini Kalluri, Forte's founder, president, CEO and chief customer officer acknowledged the honor, saying, "It's at times like these when we're reminded how fortunate we are to be in the field that we are, helping to streamline clinical research operations so that advancements in medicine can be developed faster. Our success is a direct result of an outstanding customer-focused team and a phenomenal group of customers that support our continued growth."
"We are proud to honor the 2012 Technology Fast 500™ companies, and commend them for their outstanding growth," said Eric Openshaw, vice chairman, Deloitte LLP and U.S. technology, media and telecommunications (TMT) leader. "These ground-breaking companies have outpaced their competition and are reinventing the way we do business today."
"The companies on the Fast 500 list are among those that have demonstrated remarkable innovation, creativity and business savvy," said Bill Ribaudo partner, Deloitte & Touche LLP and national TMT leader for audit and enterprise risk services (AERS). "As a result, these companies have continued to successfully forge ahead in a challenging economic environment. We applaud the leadership and employees of Forte Research Systems for this impressive accomplishment."
About Deloitte's 2012 Technology Fast 500™
Technology Fast 500, conducted by Deloitte & Touche LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies—both public and private—in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2007 to 2011.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, companies must be in business for a minimum of five years, and be headquartered within North America.
About Forte Research Systems
With a strong belief that clinical research excellence begins with the sites, Forte Research Systems offers specialized products for clinical research operations.
OnCore® is an eclinical solution for the clinical research enterprise that fully integrates CTMS, EDC, data management, billing compliance, biospecimen management, and patient registry management functionality. The system has been developed to specifically address the needs of mid-sized to large research hospitals, cancer centers, academic medical centers, and CTSAs.
Allegro® systems are cloud-based CTMS that help manage study startup, study conduct, subject visits, budgets and financials. Allegro CTMS@Site is designed for investigator sites and research groups while Allegro CTMS@Network is designed for multi-site networks and site and trial management organizations.
SOURCE Forte Research Systems